We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chewy EBITDA Margins Climb: How Close Is CHWY to Its 10% Goal?
Read MoreHide Full Article
Key Takeaways
CHWY exceeded Q3 sales guidance as adjusted EBITDA rose 30% y/y to $180.9 million.
CHWY expanded the adjusted EBITDA margin 100 bps to 5.8% through gross-margin gains and SG&A discipline.
Chewy expects margins to be within 450 bps of its 10% target by year-end.
Chewy, Inc. (CHWY - Free Report) has been on track toward its long-term adjusted EBITDA margin of 10%, as it continues to demonstrate consistent year-over-year profitability improvement, with third-quarter fiscal 2025 results building on the momentum established in the first half of the year. The quarter underscored the structural resilience of Chewy’s business model and strong execution across the organization, as the company exceeded the high end of its net sales guidance, expanded margins and accelerated free cash flow generation.
Adjusted EBITDA increased 30% year over year to $180.9 million in the fiscal third quarter, with the adjusted EBITDA margin expanding 100 basis points to 5.8%. The improvement reflected a solid gross margin execution, disciplined sales and general administrative (SG&A) expenses, and continued efficiency in advertising and marketing spend.
Chewy expects its fiscal 2025 adjusted EBITDA margin between 5.6% and 5.7%. Initiatives like the expansion of Chewy Vet Care and the Chewy+ membership program are designed to deepen customer engagement and support long-term margin appreciation. The recent acquisition of SmartEquine is also expected to be accretive to margins upon closing.
Chewy remains confident in its long-term goal of achieving a 10% adjusted EBITDA margin. At a 5.8% margin in the fiscal third quarter, management indicated that less than 450 basis points of expansion are required to reach the long-term target. Roughly half of the margin expansion is expected to come from further gross margin improvement, with the balance driven by operating expense efficiencies.
Overall, Chewy’s fiscal third-quarter performance reinforces tangible progress toward its long-term profitability ambitions. With scalable gross margin levers, disciplined cost control and efficiency initiatives, the company appears well-positioned to sustain margin expansion beyond fiscal 2025.
Chewy Faces Competition From Petco & Bark
Petco Health & Wellness Company, Inc. (WOOF - Free Report) saw a 3.1% year-over-year decline in net sales to $1.5 billion in the third quarter of fiscal 2025, in line with the company’s third-quarter outlook. Despite the revenue softness, adjusted EBITDA of Petco rose by $17.3 million to $98.6 million, reflecting improved profitability, driven by effective cost management and operational execution in the quarter.
BARK, Inc.’s (BARK - Free Report) revenue totaled $107 million, exceeding the company’s guidance of $102-$105 million. However, total revenues declined 15.2% year over year due to fewer total orders stemming from a lower level of subscriptions carried into second-quarter fiscal 2026. Bark reported an adjusted EBITDA loss of $1.4 million, within the company’s guidance between a $2 million loss and breakeven.
From a valuation standpoint, CHWY trades at a forward price-to-earnings ratio of 21.14, lower than the industry’s average of 24.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for earnings estimates for the current and next fiscal years indicates year-over-year growth of 22.1% and 23.3%, respectively.
Image Source: Zacks Investment Research
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Chewy EBITDA Margins Climb: How Close Is CHWY to Its 10% Goal?
Key Takeaways
Chewy, Inc. (CHWY - Free Report) has been on track toward its long-term adjusted EBITDA margin of 10%, as it continues to demonstrate consistent year-over-year profitability improvement, with third-quarter fiscal 2025 results building on the momentum established in the first half of the year. The quarter underscored the structural resilience of Chewy’s business model and strong execution across the organization, as the company exceeded the high end of its net sales guidance, expanded margins and accelerated free cash flow generation.
Adjusted EBITDA increased 30% year over year to $180.9 million in the fiscal third quarter, with the adjusted EBITDA margin expanding 100 basis points to 5.8%. The improvement reflected a solid gross margin execution, disciplined sales and general administrative (SG&A) expenses, and continued efficiency in advertising and marketing spend.
Chewy expects its fiscal 2025 adjusted EBITDA margin between 5.6% and 5.7%. Initiatives like the expansion of Chewy Vet Care and the Chewy+ membership program are designed to deepen customer engagement and support long-term margin appreciation. The recent acquisition of SmartEquine is also expected to be accretive to margins upon closing.
Chewy remains confident in its long-term goal of achieving a 10% adjusted EBITDA margin. At a 5.8% margin in the fiscal third quarter, management indicated that less than 450 basis points of expansion are required to reach the long-term target. Roughly half of the margin expansion is expected to come from further gross margin improvement, with the balance driven by operating expense efficiencies.
Overall, Chewy’s fiscal third-quarter performance reinforces tangible progress toward its long-term profitability ambitions. With scalable gross margin levers, disciplined cost control and efficiency initiatives, the company appears well-positioned to sustain margin expansion beyond fiscal 2025.
Chewy Faces Competition From Petco & Bark
Petco Health & Wellness Company, Inc. (WOOF - Free Report) saw a 3.1% year-over-year decline in net sales to $1.5 billion in the third quarter of fiscal 2025, in line with the company’s third-quarter outlook. Despite the revenue softness, adjusted EBITDA of Petco rose by $17.3 million to $98.6 million, reflecting improved profitability, driven by effective cost management and operational execution in the quarter.
BARK, Inc.’s (BARK - Free Report) revenue totaled $107 million, exceeding the company’s guidance of $102-$105 million. However, total revenues declined 15.2% year over year due to fewer total orders stemming from a lower level of subscriptions carried into second-quarter fiscal 2026. Bark reported an adjusted EBITDA loss of $1.4 million, within the company’s guidance between a $2 million loss and breakeven.
Zacks Rundown for CHWY
CHWY shares have lost 25.2% in the last six months against the industry’s rise of 8.1%. Chewy carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a forward price-to-earnings ratio of 21.14, lower than the industry’s average of 24.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for earnings estimates for the current and next fiscal years indicates year-over-year growth of 22.1% and 23.3%, respectively.
Image Source: Zacks Investment Research